CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.

Media Contact: PR@califesciences.org

FAST Program to Support Five Startups from Southern California

Sep 1, 2021

Now beginning its ninth year, the California Life Sciences FAST Advisory Program has extended its reach this fall serving five young companies from the Los Angeles/Orange County and San Diego regions.

Read More

A Note About Pantheon 2021

Aug 27, 2021

The coronavirus pandemic continues to have an impact on California Life Sciences event planning, in particular our annual Pantheon celebration. The need for social distancing has meant that bringing large groups of people together isn’t viable right now.

Read More

Policy Priority: R&D Tax Credit and NOL Deductions

Aug 27, 2021

The restoration of California’s Research and Development (R&D) tax credit and Net Operating Loss (NOL) deduction has been one of California Life Sciences’ (CLS) top priorities for 2021.

Read More

California Life Sciences to Support MedTechColor: Championing Persons of Color Who Are Making Meaningful Contributions to the Life Sciences Ecosystem

Aug 25, 2021

California Life Sciences (CLS), has partnered with MedTech Color, a non-profit organization with a mission to advance the representation of persons of color in the medtech industry. Last spring, CLS supported the 2021 Annual MedTech Color (MTC) Virtual Pitch Competition, aimed to celebrate innovative ideas from early-stage start-up companies who have raised less than one..

Read More

Emerging Innovators: Q3 Updates

Aug 17, 2021

FAST / CARB-X / Emerging Innovators News Applied Molecular Transport, LLC. (FAST Spring 2014) (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced additional Phase 1b data for oral AMT-101 in ulcerative colitis (UC) patients. Read more GigaGen Inc. (FAST Spring 2015), a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint..

Read More

Updates on Local Health Orders: San Francisco and Los Angeles County

Aug 16, 2021

California Life Sciences (CLS) continues to monitor health orders across the state of California to understand the possible impact on our member companies and constituents. Two health orders that have been released recently impact San Francisco and Los Angeles Counties employers and healthcare workers. San Francisco Health Order Requires Vaccination in Certain Indoor Settings San..

Read More